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Introduction
============

Multivesicular bodies (MVBs) are late endosomes containing lumenal vesicles formed by invagination of the limiting endosomal membrane. The MVB vesicles are delivered into the hydrolytic lumen of the lysosome/vacuole upon fusion of the limiting MVB membrane with the lysosomal/vacuolar membrane. A variety of cell surface receptors down-regulated from the plasma membrane are sorted into MVB vesicles en route to being degraded, including many growth factor receptor tyrosine kinases in animals and G protein-coupled pheromone receptors in the budding yeast *Saccharomyces cerevisiae*. In yeast, several biosynthetic enzymes are also sorted into MVB vesicles during their transport from the Golgi to the vacuole (for review see [@bib16]).

Ubiquitination mediates the sorting of integral membrane proteins into the MVB pathway. Ubiquitin (Ub) is a highly conserved 76-aa polypeptide that is covalently linked to specific protein substrates by a cascade of Ub-conjugation enzymes. Ubiquitination was first characterized to occur on soluble proteins that are polyubiquitinated via the attachment of a chain of four or more Ub subunits, which targets these substrates for degradation by the proteasome ([@bib39]). In contrast, MVB cargo proteins are monoubiquitinated via the linkage of a single Ub subunit (or a chain of two to three subunits) to their cytoplasmic domains ([@bib16]). Ub is removed from both polyubiquitinated and monoubiquitinated proteins by deubiquitinating enzymes, thereby enabling cells to maintain a constant pool of Ub ([@bib39]; [@bib40]).

The sorting of ubiquitinated MVB cargoes is controlled by class E Vps proteins, a set of conserved cytoplasmic proteins that associate with endosomal membranes. Several class E Vps proteins coassemble into distinct complexes that bind to ubiquitinated cargo proteins and guide them into the MVB pathway. In yeast, cargoes initially bind the Vps27--Hse1 complex and subsequently interact with the ESCRT-I complex (Vps23, Vps28, and Vps37; [@bib6]; [@bib21]). The ESCRT-II (Vps22, Vps25, and Vps36) and ESCRT-III (Vps2, Vps20, Vps24, and Snf7) complexes function downstream of ESCRT-I ([@bib4], [@bib5]), but their precise roles are not known. In mammalian cells, class E Vps orthologues also mediate the sorting of MVB cargo proteins ([@bib16]). Furthermore, this machinery is exploited by certain enveloped viruses in order to escape from host cells. For example, Tsg101, the mammalian orthologue of yeast Vps23, is recruited to HIV-1 budding sites at the plasma membrane by directly interacting with ubiquitinated viral Gag proteins (for review see [@bib31]).

Additional class E Vps proteins function in the MVB pathway in yeast, including Vps4, an AAA-type ATPase that catalyzes the dissociation of ESCRT complexes from endosomal membranes ([@bib4],[@bib5]). Vps4 also functions in the endosomal dissociation of Bro1, a class E Vps protein required for the deubiquitination of cargo proteins at a late stage of the MVB pathway downstream of the ESCRT-III complex ([@bib25]; [@bib27]). The association of Bro1 with endosomes requires Snf7 ([@bib27]), and the mammalian Bro1 orthologue, Alix (also known as Aip1), has been shown to bind the mammalian Snf7 orthologue, CHMP4b ([@bib19]; [@bib23]; [@bib29]; [@bib34]; [@bib38]). Studies of HIV-1--infected cells have revealed that Alix/Aip1 also binds Tsg101 during viral budding from the plasma membrane ([@bib34]; [@bib38]), suggesting that Alix/Aip1 bridges an interaction between the ESCRT-I and -III complexes. Interestingly, Alix/Aip1 binds specifically to synthetic liposomes containing lysobisphosphatidic acid and appears to antagonize the ability of this unconventional phospholipid to promote membrane invagination ([@bib24]), but the role of Alix/Aip1 in controlling membrane dynamics is not clear.

Here, we report that the defects in MVB sorting caused by the loss of Bro1 function in yeast are suppressed by overexpression of the *DOA4* gene, which encodes the Ub thiolesterase required for the removal of Ub from MVB cargo proteins ([@bib12]; [@bib20]; [@bib22]). Specifically, our data demonstrate that high-copy expression of *DOA4* restores cargo protein deubiquitination and subsequent transport via the MVB pathway in *bro1* mutant cells. The catalytic activity of Doa4 is essential for its role as a suppressor, indicating that the mechanism of suppression involves substrate deubiquitination. Furthermore, the multivesicular morphology of late endosomes, which is abnormal in *bro1* mutant cells, is restored by the overexpression of *DOA4*. The ability of high-copy *DOA4* to suppress the loss of Bro1 function is explained by our finding that Bro1 is essential for the localization of Doa4 to endosomes and that Bro1 and Doa4 physically interact on endosomal membranes. Therefore, Bro1 has a crucial role in coordinating substrate deubiquitination in the MVB pathway by recruiting Doa4 to endosomes.

Results
=======

The coiled-coil domain of Bro1 is essential for MVB sorting
-----------------------------------------------------------

Many class E Vps proteins have one or more coiled-coil domains, which are structural elements that typically mediate protein--protein interactions. Bro1 has a central coiled-coil domain spanning residues 543-583 ([Fig. 1](#fig1){ref-type="fig"} A). We constructed a mutant allele (*bro1* ^Δ^ *^CC^*) in which the sequence encoding this domain had been deleted, and then integrated the *bro1* ^Δ^ *^CC^* allele by homologous recombination into the genome in place of the wild-type *BRO1* gene. To determine whether MVB sorting was functional in *bro1* ^Δ^ *^CC^* cells, we examined the intracellular localization of a fusion protein in which GFP was attached to the cytoplasmic domain of carboxypeptidase S (CPS), a biosynthetic enzyme that is sorted via the MVB pathway during its transport from the Golgi to the vacuole ([@bib26]). GFP-CPS was found entirely within the vacuole lumen of wild-type cells ([Fig. 1](#fig1){ref-type="fig"} B). In contrast, GFP-CPS in *bro1* ^Δ^ *^CC^* cells was observed at the vacuole membrane ([Fig. 1](#fig1){ref-type="fig"} B), which is indicative of a defect in sorting of the fusion protein via the MVB pathway ([@bib26]). GFP-CPS was also mislocalized to class E compartments ([Fig. 1](#fig1){ref-type="fig"} B, arrowheads), abnormal late endosomal structures that occur in all class E *vps* mutant cells. A similar defect in the localization of GFP-CPS was seen in *bro1*Δ cells in which the entire *BRO1* coding sequence had been deleted ([Fig. 1](#fig1){ref-type="fig"} B). In addition, we observed in both *bro1* ^Δ^ *^CC^* and *bro1*Δ mutant cells that Ste3-GFP, an MVB cargo protein endocytosed from the plasma membrane ([@bib35]), failed to be sorted into the vacuole lumen (unpublished data). Thus, the coiled-coil domain of Bro1 is essential for the function of Bro1 in the MVB pathway.

![**The coiled-coil domain of Bro1 is essential for CPS transport via the MVB pathway.** (A) Schematic diagram of Bro1 indicating the locations of the Bro1 domain (BOD), the coiled-coil domain (CC), and the proline-rich domain (PRD). (B and C) Fluorescence and DIC microscopy of BHY10, GOY57 and KGY1 cells expressing a *GFP-CPS* fusion. In C, cells were transformed with a high-copy (2 μ) plasmid encoding *bro1* ^Δ^ *^CC^* or wild-type *BRO1*. Arrowheads indicate class E compartments (B) and class E compartment-like structures (C). Bars, 2.5 μm.](200403139f1){#fig1}

Interestingly, when we overexpressed the *bro1* ^Δ^ *^CC^* mutant allele in wild-type cells, GFP-CPS was mislocalized both to the vacuole membrane and to a structure that resembles the class E compartment ([Fig. 1](#fig1){ref-type="fig"} C). In contrast, overexpression of the wild-type *BRO1* gene had no deleterious effect on the localization of GFP-CPS ([Fig. 1](#fig1){ref-type="fig"} C). The overexpression of *bro1* ^Δ^ *^CC^*, therefore, causes a dominant-negative phenotype, possibly because the mutant gene product interferes with the function of the wild-type Bro1 protein.

The coiled-coil domain is not required for Bro1 to associate with endosomes
---------------------------------------------------------------------------

We previously demonstrated that Bro1 is a cytoplasmic protein which associates with endosomal compartments and that the dissociation of Bro1 from endosomes requires the ATPase activity of Vps4 ([@bib27]). Thus, when we replaced the wild-type *BRO1* gene with a genomically integrated *BRO1-GFP* gene fusion in cells that have normal Vps4 function (*VPS4* ^+^), we observed multiple fluorescent punctate structures in addition to diffuse cytoplasmic fluorescence ([Fig. 2](#fig2){ref-type="fig"} A). Upon deletion of the *VPS4* gene (*vps4*Δ), the GFP fluorescence was concentrated at class E compartments, which had formed in these cells due to the absence of Vps4 activity ([Fig. 2](#fig2){ref-type="fig"} B). The cells in these experiments shown in [Fig. 2](#fig2){ref-type="fig"} (and in [Figs. 6](#fig6){ref-type="fig"}, [7](#fig7){ref-type="fig"}, and [9](#fig9){ref-type="fig"}) were also labeled by a brief pulse of FM 4-64 followed by incubation in label-free medium. FM 4-64 is a fluorescent lipophilic compound that intercalates into the plasma membrane and is endocytosed, resulting in the staining of vacuole membranes and class E compartments ([@bib36]).

![**The Bro1 coiled-coil domain is not required for endosomal localization of Bro1.** Fluorescence and DIC microscopy of DMY1 (A), DMY2 (B), DBY15 (C), and DBY18 (D) cells stained with FM 4-64. Closed arrowheads indicate class E compartments costained by FM 4-64. Open arrowheads indicate GFP-positive structures not labeled by FM 4-64. Bars, 2.5 μm.](200403139f2){#fig2}

To determine if the coiled-coil domain is required for the association of Bro1 with endosomes, we integrated a *bro1* ^Δ^ *^CC^*-GFP gene fusion in place of the wild-type *BRO1* gene. Both in *VPS4* ^+^ and *vps4*Δ cells expressing *bro1* ^Δ^ *^CC^*-GFP, fluorescence was localized at class E compartments that were costained by FM 4-64 ([Fig. 2, C and D](#fig2){ref-type="fig"}, closed arrowheads). Class E compartments had formed in *VPS4* ^+^ cells expressing *bro1* ^Δ^ *^CC^*-GFP in place of wild-type *BRO1* due to the fact that the coiled-coil domain is required for the function of Bro1 in the MVB pathway ([Fig. 1](#fig1){ref-type="fig"}). Electron microscopic analysis of immunogold labeled cell sections confirmed that the bro1^ΔCC^-GFP fusion protein was, indeed, associated with class E compartments in both *VPS4* ^+^ and *vps4*Δ cells (not depicted). Interestingly, in contrast with wild-type Bro1-GFP, bro1^ΔCC^-GFP was also localized in both strains to additional punctate structures that were not labeled by FM 4-64 ([Fig. 2, C and D](#fig2){ref-type="fig"}, open arrowheads). However, the localization of bro1^ΔCC^-GFP to class E compartments indicates that the coiled-coil domain per se is not required for the localization of Bro1 to late endosomes.

Overexpression of *DOA4* suppresses CPY sorting defects in *bro1* mutant cells
------------------------------------------------------------------------------

To identify proteins that may be able to restore normal function of the MVB pathway when over-produced in the *bro1* ^Δ^ *^CC^* mutant strain, we designed a genetic screen based upon another phenotype observed in *bro1* mutant cells. In addition to MVB sorting defects, *bro1* mutants inefficiently sort a soluble vacuolar enzyme, carboxypeptidase Y (CPY). Newly synthesized CPY is transported from the ER to the Golgi, where it binds a transmembrane receptor, Vps10. In wild-type cells ([Fig. 3](#fig3){ref-type="fig"} A), the Vps10--CPY complex is sorted from the Golgi to endosomes, whereupon CPY dissociates from Vps10, and the receptor recycles back to the Golgi, whereas CPY is transported further toward the vacuole ([@bib8]; [@bib10]). The class E compartments that are formed in *bro1* mutant cells prevent Vps10 from efficiently recycling to the Golgi ([Fig. 3](#fig3){ref-type="fig"} B), resulting in a significant portion of newly synthesized CPY entering by default into the secretory pathway ([@bib27]). Thus, the secretion of CPY by *bro1* mutant cells is likely to be an indirect consequence of the aberrant endosomal morphology that occurs upon the loss of Bro1 function.

![***DOA4* overexpression in *bro1* mutant cells suppresses CPY-Inv secretion.** Schematic diagram of the trafficking of CPY in wild-type cells (A) and in *bro1* mutant cells (B). Not depicted in A is the fusion of the endosome/MVB with the vacuole. PM, plasma membrane. (C--E) Quantitation of CPY-Inv secretion by BHY10, GOY57, and KGY1 cells transformed either with the empty high-copy (2 μ) plasmid (C), the 2 μ plasmid containing the wild-type *DOA4* gene (D), or the 2 μ plasmid containing the mutant *doa4* ^C/S^ allele (E). The bar graph depicts the mean ± standard error from multiple independent experiments ([Table I](#tbl1){ref-type="table"}).](200403139f3){#fig3}

The percentage of total cellular CPY that is secreted can be measured quantitatively using a colorimetric assay that monitors the enzymatic activity of a CPY-invertase (CPY-Inv) fusion protein ([@bib11]). As shown in [Fig. 3](#fig3){ref-type="fig"} C, wild-type cells secreted ∼1% of CPY-Inv, whereas *bro1*Δ cells secreted 10--15 times this amount. The *bro1* ^Δ^ *^CC^* mutant strain secreted nearly the same percentage as *bro1*Δ cells ([Fig. 3](#fig3){ref-type="fig"} C), which is consistent with the coiled-coil domain being essential for the function of Bro1 in the MVB pathway.

The colorimetric assay for invertase activity can also be used to detect the secretion of CPY-Inv by cells growing on solid medium ([@bib11]). We used this assay in a genetic screen to identify any gene that, when overexpressed in *bro1* ^Δ^ *^CC^* cells, reduced the amount of secreted CPY-Inv. We reasoned that such a high-copy suppressor would encode a protein that interacts with Bro1 and would be able to restore normal function of the MVB pathway when over produced. Thus, we transformed the *bro1* ^Δ^ *^CC^* strain with a high-copy plasmid library of yeast genomic DNA and identified colonies that secreted less CPY-Inv relative to the *bro1* ^Δ^ *^CC^* strain. One clone contained a plasmid that could reproducibly suppress CPY-Inv secretion. Nucleotide sequence analysis revealed that this suppressor plasmid contained a 7.3-kb fragment of chromosome IV that includes the complete ORF of five genes, one of which is *DOA4*.

The *DOA4* gene product is a member of the Ub-specific processing protease (UBP) family of Ub thiolesterases ([@bib40]). Doa4 is the UBP required for removal of Ub from the cytoplasmic domain of CPS and other MVB cargo proteins ([@bib12]; [@bib20]; [@bib22]), and subcloning confirmed that *DOA4* is the gene within the library plasmid responsible for suppression of the *bro1* ^Δ^ *^CC^* phenotype (unpublished data). The suppression of CPY-Inv secretion mediated by *DOA4* overexpression is shown in [Fig. 3](#fig3){ref-type="fig"} D and [Table I](#tbl1){ref-type="table"}. High-copy *DOA4* reduced the percentage of CPY-Inv secreted by *bro1* ^Δ^ *^CC^* cells by approximately threefold. In contrast, *DOA4* overexpression resulted in approximately threefold more CPY-Inv secreted by wild-type cells, indicating that high-copy *DOA4* caused a subtle dominant-negative phenotype. Surprisingly, *DOA4* overexpression reduced by approximately twofold the amount of CPY-Inv secreted by *bro1*Δ cells, indicating a partial bypass of Bro1.

###### 

**Effect of** *DOA4* **over-expression on CPY-Inv secretion and GFP-CPS sorting**

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Strain                               −/+ 2 µ *DOA4* [a](#tfn1){ref-type="table-fn"}   Percentage of secreted CPY-Inv[b](#tfn2){ref-type="table-fn"}                  GFP-CPS localization
  ------------------------------------ ------------------------------------------------ ------------------------------------------------------------------------------ -----------------------------------------
  Wild-type                            −\                                               1.0 ± 2.1[c](#tfn3){ref-type="table-fn"} (5)[d](#tfn4){ref-type="table-fn"}\   VL[e](#tfn5){ref-type="table-fn"}\
                                       +                                                2.8 ± 1.5 (4)                                                                  VL

  *bro1* ^ΔCC^                         −\                                               11.5 ± 4.7 (24)\                                                               VM + EC[f](#tfn6){ref-type="table-fn"}\
                                       +                                                3.7 ± 2.5 (7)                                                                  VL

  *bro1Δ*                              −\                                               13.0 ± 3.8 (6)\                                                                VM + EC\
                                       +                                                5.6 ± 2.4 (5)                                                                  VL + VM + EC

  *vps4Δ*                              −\                                               39.4 ± 2.5 (3)\                                                                VM + EC\
                                       +                                                5.2 ± 1.7 (3)                                                                  VM + EC

  *bro1Δ vps4Δ*                        −\                                               43.7 ± 6.9 (3)\                                                                VM + EC\
                                       +                                                46.0 ± 7.1 (3                                                                  VM + EC

  *bro1* ^ΔCC^ *vps4Δ*                 −\                                               35.2 ± 2.9 (3)\                                                                VM + EC\
                                       +                                                35.9 ± 4.1 (3)                                                                 VM + EC

  ESCRT-I mutants                                                                                                                                                      

  *vps23Δ*                             −\                                               20.0 ± 5.9 (3)\                                                                VM + EC\
                                       +                                                17.6 ± 2.0 (3)                                                                 VM + EC

  *vps28Δ*                             −\                                               13.4 ± 1.2 (3)\                                                                VM + EC\
                                       +                                                21.7 ± 4.2 (3)                                                                 VM + EC

  *vps37Δ*                             −\                                               16.3 ± 1.7 (3)\                                                                VL[g](#tfn7){ref-type="table-fn"}\
                                       +                                                15.8 ± 1.3 (3)                                                                 VL

  ESCRT-II mutants                                                                                                                                                     

  *vps22Δ*                             −\                                               20.1 ± 4.5 (3)\                                                                VM + EC\
                                       +                                                20.5 ± 6.1 (3)                                                                 VM + EC

  *vps25Δ*                             −\                                               23.1 ± 1.0 (3)\                                                                VM + EC\
                                       +                                                20.7 ± 0.9 (3)                                                                 VM + EC

  *vps36Δ*                             −\                                               24.2 ± 6.3 (3)\                                                                VM + EC\
                                       +                                                20.6 ± 4.1 (3)                                                                 VM + EC

  ESCRT-III mutants                                                                                                                                                    

  *vps2Δ*                              −\                                               25.2 ± 5.0 (3)\                                                                VM + EC\
                                       +                                                27.8 ± 6.5 (3)                                                                 VM + EC

  *vps24Δ*                             −\                                               29.1 ± 4.3 (3)\                                                                VM + EC\
                                       +                                                30.9 ± 4.4 (3)                                                                 VM + EC

  *vps20Δ*                             −\                                               24.2 ± 2.9 (3)\                                                                VM + EC\
                                       +                                                20.1 ± 6.5 (3)                                                                 VM + EC

  *snf7Δ*                              −\                                               25.8 ± 5.0 (3)\                                                                VM + EC\
                                       +                                                24.6 ± 1.1 (3)                                                                 VM + EC

  Other class E *vps* mutants tested                                                                                                                                   

  *vps27Δ*                             −\                                               28.0 ± 1.5 (3)\                                                                VM + EC\
                                       +                                                26.5 ± 2.6 (3)                                                                 VM + EC

  *nhx1Δ*                              −\                                               41.8 ± 13.0 (3)\                                                               VL[g](#tfn7){ref-type="table-fn"}\
                                       +                                                39.1 ± 13.0 (3)                                                                VL

  *vps60Δ*                             −\                                               17.7 ± 1.3 (3)\                                                                VM + EC\
                                       +                                                19.0 ± 5.5 (3)                                                                 VM + EC
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Strains were transformed with the empty 2 µ vector (−) or the 2 µ vector containing *DOA4* (+).

The percentage of total cellular CPY-Inv secreted by cells.

Mean ± standard error.

Number of independent experiments.

Vacuole lumen.

Vacuole membrane and class E compartment.

There was no noticeable defect in GFP-CPS sorting in *vps37*Δ and *nhx1*Δ cells.

The catalytic region of UBP enzymes have a conserved three-domain architecture that includes a critical cysteine residue, which forms a thiolester bond with Ub ([@bib18]). We constructed a point mutant allele (*doa4* ^C/S^) in which the corresponding cysteine in Doa4 (Cys^571^) had been changed to a serine residue. The *doa4* ^C/S^ allele failed to suppress CPY-Inv secretion when overexpressed in either *bro1* ^Δ^ *^CC^* or *bro1*Δ cells. Instead, *doa4* ^C/S^ overexpression enhanced the mutant phenotype in both strains and caused a stronger dominant-negative phenotype in wild-type cells ([Fig. 3](#fig3){ref-type="fig"} E). Catalytic activity, therefore, is essential for high-copy *DOA4* to suppress CPY-Inv secretion caused by the loss of Bro1 function.

Because high-copy *DOA4* partially suppressed the *bro1*Δ phenotype, we determined whether the loss of any class E Vps protein could be bypassed by *DOA4* overexpression. We transformed either the empty library vector or the library plasmid containing *DOA4* into strains in which individual class E *VPS* genes had been deleted, and then measured the percentage of secreted CPY-Inv ([Table I](#tbl1){ref-type="table"}). Suppression failed to occur in strains in which components of the ESCRT-I, -II, or -III complexes had been deleted ([Table I](#tbl1){ref-type="table"}). High-copy *DOA4* also could not suppress the loss of other class E Vps proteins, including Vps27 ([Table I](#tbl1){ref-type="table"}), which functions upstream of the ESCRT-I complex in the recognition of ubiquitinated MVB cargo proteins ([@bib6]; [@bib21]). Interestingly, *DOA4* overexpression suppressed the secretion of CPY-Inv by *vps4*Δ cells but could not suppress either *bro1*Δ *vps4*Δ or *bro1* ^Δ^ *^CC^ vps4*Δ double mutant cells ([Table I](#tbl1){ref-type="table"}). These observations suggest that high-copy *DOA4* suppresses the CPY sorting defects in *bro1* and *vps4* mutants by different mechanisms.

High-copy *DOA4* suppresses CPS deubiquitination and sorting defects in *bro1* ^Δ^ *^CC^* mutant cells
------------------------------------------------------------------------------------------------------

We had hypothesized that a high-copy suppressor of the aberrant secretion of CPY-Inv by *bro1* mutant cells would restore normal function of the MVB pathway. Indeed, when we examined the localization of GFP-CPS in *bro1* ^Δ^ *^CC^* cells overexpressing *DOA4*, most of the fusion protein was seen inside the vacuole lumen, with only a small amount detected on the vacuole membrane ([Fig. 4](#fig4){ref-type="fig"} A). Fluorescent punctate structures were not evident in these cells, suggesting that class E compartment formation was significantly reduced. We also observed more GFP-CPS within the vacuole lumen of *bro1*Δ cells overexpressing *DOA4* ([Fig. 4](#fig4){ref-type="fig"} B) compared with *bro1*Δ cells alone ([Fig. 1](#fig1){ref-type="fig"} B). However, compared with *bro1* ^Δ^ *^CC^* cells that overexpress *DOA4* ([Fig. 4](#fig4){ref-type="fig"} A), much more GFP-CPS in *bro1*Δ cells overexpressing *DOA4* was seen at the vacuole membrane and at structures that resembled class E compartments ([Fig. 4](#fig4){ref-type="fig"} B). Thus, high-copy *DOA4* is much less efficient at suppressing the defect in GFP-CPS sorting in *bro1*Δ compared with *bro1* ^Δ^ *^CC^* cells.

![***DOA4* overexpression in *bro1*** ^Δ***CC***^ **mutant cells restores the sorting and deubiquitination of CPS.** (A--D) Fluorescence and DIC microscopy of GOY57 (A), KGY1 (B), BHY10 (C), and DBY42 (D) cells expressing the *GFP-CPS* fusion and transformed with 2 μ *DOA4*. Arrowheads indicate class compartments. Bars, 2.5 μm. (E) Immunoprecipitates of CPS were examined by Western blotting using anti-Ub or anti-CPS antibodies. Note that the lumenal domain of CPS is differentially glycosylated and is observed as a doublet. (F) Quantitation of the intensities of Ub-CPS versus CPS present in each lane in E. Bar graph depicts mean values ± SD from two independent experiments.](200403139f4){#fig4}

Although the overexpression of *DOA4* in *vps4*Δ cells suppressed CPY-Inv secretion ([Table I](#tbl1){ref-type="table"}), it did not restore the sorting of GFP-CPS into the vacuole lumen. As shown in [Fig. 4](#fig4){ref-type="fig"} D, GFP-CPS was mislocalized to the vacuole membrane and the class E compartment in *vps4*Δ cells overexpressing *DOA4*, which is identical to the mislocalization of GFP-CPS in *vps4*Δ cells ([@bib26]). High-copy *DOA4* also failed to restore the sorting of GFP-CPS via the MVB pathway in other class E *vps* mutants ([Table I](#tbl1){ref-type="table"}).

In *doa4* mutant cells, CPS and other MVB cargoes accumulate in their ubiquitinated forms ([@bib12]; [@bib20]; [@bib22]). We recently showed that ubiquitinated CPS (Ub-CPS) also accumulates in *bro1*Δ cells ([@bib27]). Therefore, we investigated whether *DOA4* overexpression could alleviate the defect in CPS deubiquitination that occurs upon loss of Bro1 function. Because the deubiquitination of CPS is normally efficient, Ub-CPS was difficult to detect in wild-type cells, but a significant amount of Ub-CPS was observed in *bro1* ^Δ^ *^CC^* cells ([Fig. 4](#fig4){ref-type="fig"} E). As shown in [Fig. 4](#fig4){ref-type="fig"} (E and F), overexpression of *DOA4* completely restored CPS deubiquitination in *bro1* ^Δ^ *^CC^* cells, which is consistent with a role for Doa4 in deubiquitinating MVB cargo proteins.

Interestingly, much more Ub-CPS was observed in *bro1*Δ cells compared with the level of Ub-CPS seen in *bro1* ^Δ^ *^CC^* cells ([Fig. 4](#fig4){ref-type="fig"} E), indicating that the deubiquitination of CPS is more severely compromised if the Bro1 protein is absent. Furthermore, the amount of Ub-CPS in *bro1*Δ mutants was much less significantly reduced upon overexpression of *DOA4*, in contrast with the complete restoration of CPS deubiquitination that occurred in *bro1* ^Δ^ *^CC^* cells. This result is consistent with our observation that high-copy *DOA4* was much more effective at suppressing the GFP-CPS sorting defect in *bro1* ^Δ^ *^CC^* cells ([Fig. 4](#fig4){ref-type="fig"} A) versus *bro1*Δ cells ([Fig. 4](#fig4){ref-type="fig"} B). Thus, excess amounts of Doa4 effectively alleviate the mutant phenotype caused by deletion of the Bro1 coiled-coil domain but cannot substitute for deletion of the entire Bro1 protein.

High-copy *DOA4* restores MVB morphology in *bro1* mutant cells
---------------------------------------------------------------

By fluorescence microscopy, it appeared that the overexpression of *DOA4* caused a reduction in the number of class E compartments in *bro1* mutant cells. Therefore, we used EM to examine the effect that high-copy *DOA4* has on endosomal ultrastructure. In wild-type cells, we readily observed MVBs, with each compartment consisting of a limiting membrane bilayer surrounding numerous vesicular profiles ([Fig. 5, A and B](#fig5){ref-type="fig"}). In contrast, MVBs were never evident in *bro1* ^Δ^ *^CC^* or *bro1*Δ cells, which, instead, contained numerous class E compartments. An example of a class E compartment seen in *bro1* ^Δ^ *^CC^* cells is shown in [Fig. 5](#fig5){ref-type="fig"} C. Similar structures were also seen in *bro1*Δ cells (not depicted).

![***DOA4* overexpression restores MVB morphology in *bro1* mutant cells.** (A) EM showing MVBs in BHY10 cells. Arrowheads indicate MVBs. n, nucleus. Bar, 0.2 μm. (B) MVBs from the boxed area shown in A. Bar, 0.1 μm. (C) EM showing a typical class E compartment in GOY57 cells. Bar, 0.1 μm. (D) EM showing multivesicular structures in GOY57 cells transformed with 2 μ *DOA4*. The arrowhead indicates a tubule projecting from an MVB toward the cytoplasm; note that the membrane bilayer of the tubule is continuous with the bilayer surrounding the lumenal vesicles. Bar, 0.1 μm. (E) MVBs and class E compartments were counted in ∼200 cells which had a diameter ≥ 2.5 μm. Each value is indicated above its respective bar in the graph and was expressed as the number per 200 cells. The multivesicular structures that had tubular projections (D, arrowhead) were counted as MVBs.](200403139f5){#fig5}

High-copy *DOA4* caused a striking change in endosomal morphology in *bro1* ^Δ^ *^CC^* mutant cells. Rather than class E compartments, we observed numerous multivesicular structures, examples of which are shown in [Fig. 5](#fig5){ref-type="fig"} D. These compartments consisted of a limiting membrane bilayer that encircled multiple vesicular profiles within the compartment lumen, which is similar to MVBs in wild-type cells ([Fig. 5](#fig5){ref-type="fig"} B). Quantitative analysis indicated that *DOA4* overexpression in *bro1* ^Δ^ *^CC^* cells caused a dramatic reduction in the number of class E compartments and resulted in almost as many MVBs as we had observed in wild-type cells ([Fig. 5](#fig5){ref-type="fig"} E). The apparent reformation of MVBs and the concomitant disappearance of class E compartments upon *DOA4* overexpression occurred to a lesser extent in *bro1*Δ cells ([Fig. 5](#fig5){ref-type="fig"} E), again indicating that high-copy *DOA4* is not as efficient at suppressing the phenotype caused by a total loss of Bro1 compared with its ability to suppress the phenotype caused by a deletion of only the Bro1 coiled-coil domain.

Interestingly, the overexpression of *DOA4* in *bro1* mutant cells occasionally resulted in multivesicular compartments having tubules projecting toward the cytoplasm that resemble the cisterna-like structures of class E compartments ([Fig. 5](#fig5){ref-type="fig"} D, arrowhead). Although further studies are needed in order to establish the identity of these unusual structures, they may correspond to intermediate MVB/class E compartments.

The localization of Doa4 to endosomes requires Bro1
---------------------------------------------------

Doa4 had previously been shown to associate with endosomal compartments ([@bib1]). Indeed, when we integrated a *DOA4-GFP* gene fusion in place of the wild-type *DOA4* gene in cells that have normal Vps4 function (*VPS4* ^+^), we observed multiple fluorescent punctate structures in addition to diffuse cytoplasmic fluorescence ([Fig. 6](#fig6){ref-type="fig"} A). This pattern of fluorescence resembles the intracellular localization of Bro1-GFP in *VPS4* ^+^ cells ([Fig. 2](#fig2){ref-type="fig"} A). Also like Bro1-GFP, Doa4-GFP was concentrated at class E compartments in *vps4*Δ cells ([Fig. 6](#fig6){ref-type="fig"} B). Doa4-GFP was also localized to class E compartments in *bro1* ^Δ^ *^CC^* and *bro1* ^Δ^ *^CC^ vps4*Δ cells ([Fig. 6, C and D](#fig6){ref-type="fig"}, closed arrowheads), indicating that the Bro1 coiled-coil domain is not required for the association of Doa4 with late endosomes. Interestingly, Doa4-GFP was localized to additional punctate structures that were not labeled by FM 4-64 in *VPS4* ^+^ and *vps4*Δ cells expressing the mutant *bro1* ^Δ^ *^CC^* allele in place of the wild-type *BRO1* gene ([Fig. 6, C and D](#fig6){ref-type="fig"}, open arrowheads), which is similar to the localization pattern of the mutant bro1^ΔCC^-GFP protein ([Fig. 2, C and D](#fig2){ref-type="fig"}).

![**Bro1 is required for the localization of Doa4 to endosomes.** Fluorescence and DIC microscopy of GOY74 (A), GOY75 (B), GOY88 (C), GOY93 (D), GOY82 (E), and GOY83 (F) cells stained with FM 4-64. Closed arrowheads indicate colocalization of GFP and FM 4-64 at class E compartments. In C and D, open arrowheads indicate GFP-positive structures not labeled by FM 4-64. In E and F, open arrowheads indicate FM 4-64--positive class E compartments at which Doa4-GFP is not localized. Bars, 2.5 μm.](200403139f6){#fig6}

A dramatic change in the localization of Doa4-GFP occurred in cells in which the *BRO1* gene had been deleted. Both in *bro1*Δ cells ([Fig. 6](#fig6){ref-type="fig"} E) and *bro1*Δ *vps4*Δ double mutant cells ([Fig. 6](#fig6){ref-type="fig"} F), Doa4-GFP failed to localize to class E compartments and was, instead, diffusely distributed. Some faintly fluorescent structures were evident at the periphery of these cells but are unlikely to be endosomes, as they were never stained when FM 4-64 was incubated continuously with cells (unpublished data), a procedure that results in staining of all compartments of the endocytic pathway ([@bib36]). Western blot analysis confirmed that the expression of full-length Doa4-GFP in *bro1*Δ and *bro1*Δ *vps4*Δ double mutant cells was equivalent to its expression in wild-type and *vps4*Δ cells (Fig. S1, available at <http://www.jcb.org/cgi/content/full/jcb.200403139/DC1>), indicating that the loss of punctate localization of Doa4-GFP in the absence of Bro1 was not due to aberrant cleavage of the fusion protein. Furthermore, transformation of a plasmid encoding the wild-type *BRO1* gene into *bro1*Δ and *bro1*Δ *vps4*Δ cells restored the localization of Doa4-GFP to endosomal compartments (unpublished data). Thus, Bro1 is essential for the localization of Doa4 to endosomes.

To test whether the endosomal localization of Bro1 is likewise dependent on Doa4, we examined the localization of Bro1-GFP in cells in which the *DOA4* gene had been deleted. In *doa4*Δ *VPS4* ^+^ cells, we observed punctate fluorescent structures in addition to diffuse cytoplasmic fluorescence ([Fig. 7](#fig7){ref-type="fig"} A), whereas in *doa4*Δ *vps4*Δ double mutant cells, the GFP fluorescence was concentrated at class E compartments ([Fig. 7](#fig7){ref-type="fig"} B). This pattern of fluorescence was virtually identical to the intracellular localization of Bro1-GFP in *VPS4* ^+^ and *vps4*Δ cells ([Fig. 2](#fig2){ref-type="fig"}). Therefore, Doa4 is not required for the endosomal localization of Bro1.

![**Doa4 is not required for the localization of Bro1 to endosomes.** Fluorescence and DIC microscopy of GOY69 (A) and GOY70 (B) cells stained with FM 4-64. Arrowheads indicate class E compartments. Bars, 2.5 μm.](200403139f7){#fig7}

Doa4 interacts with Bro1
------------------------

Because Bro1 is required for the endosomal localization of Doa4, we investigated whether Doa4 physically interacts with Bro1 by immunoprecipitating the Doa4-GFP fusion protein from detergent-solubilized extracts of yeast cell lysates under native conditions. As shown in [Fig. 8](#fig8){ref-type="fig"} A, Bro1-HA and bro1^ΔCC^-HA fusion proteins coimmunoprecipitated with Doa4-GFP from total extracts of *VPS4* ^+^ and *vps4*Δ cells. Control immunoprecipitations from lysates of strains not expressing *DOA4-GFP* confirmed that the isolation of Bro1-HA using anti-GFP antiserum required Doa4 (Fig. S2, available at <http://www.jcb.org/cgi/content/full/jcb.200403139/DC1>). Furthermore, the interaction between Bro1-HA and Doa4-GFP also occurred in anti-HA immunoprecipitations followed by anti-GFP Western blots (unpublished data).

![**Doa4 interacts with Bro1 and the mutant Bro1** ^Δ**CC**^ **protein on membranes.** (A) Detergent extracts of total lysates from GOY107, GOY108, GOY106, and GOY105 cells were subjected to immunoprecipitation with rabbit anti-GFP polyclonal antiserum under native conditions and examined by Western blotting. (B) Cell lysates were separated into membrane pellet (P) and soluble (S) fractions and extracted with detergent before immunoprecipitation and Western blot analysis.](200403139f8){#fig8}

We tested whether the interaction between Doa4 and Bro1 occurred on membranes and/or in the cytoplasm by centrifuging cell lysates before immunoprecipitation in order to generate a pellet fraction enriched in late endosomal membranes and a supernatant fraction containing soluble proteins ([@bib27]). As shown in [Fig. 8](#fig8){ref-type="fig"} B, more Bro1-HA and bro1^ΔCC^-HA coimmunoprecipitated with Doa4-GFP from the membrane fraction of *VPS4* ^+^ cells; however, these interactions were more significantly enriched in membrane extracts considering that the vast majority of Doa4-GFP in *VPS4* ^+^ cells was recovered from the soluble fraction ([Fig. 8](#fig8){ref-type="fig"} B). In *vps4*Δ cells, the interaction between Doa4-GFP and both Bro1-HA and bro1^ΔCC^-HA occurred almost exclusively in the membrane fraction, again despite the fact that more Doa4-GFP was immunoprecipitated from the soluble fraction ([Fig. 8](#fig8){ref-type="fig"} B). Altogether, these results indicate that Doa4 associates with Bro1 on membranes and that the coiled-coil domain is not required for this interaction to occur.

Endosomal localization of Doa4 in ESCRT-III mutant cells
--------------------------------------------------------

A previous study had suggested that the association of Doa4 with endosomes was dependent on two other class E Vps proteins, Vps24 and Snf7 ([@bib1]). Both Vps24 and Snf7 are components of the ESCRT-III complex that oligomerizes on endosomal membranes ([@bib4]). We recently showed that the endosomal localization of Bro1 requires Snf7 but not Vps24, suggesting that Snf7 has a role in the recruitment or stabilization of Bro1 at endosomes ([@bib27]). Therefore, we examined the localization of Doa4-GFP in *vps4*Δ cells in which either *VPS24* or *SNF7* had been deleted. In contrast with the previous analysis of Doa4 localization ([@bib1]), we observed Doa4-GFP at class E compartments in *vps24*Δ *vps4*Δ double mutant cells ([Fig. 9](#fig9){ref-type="fig"} A). However, Doa4-GFP was diffusely distributed in *snf7*Δ *vps4*Δ double mutants ([Fig. 9](#fig9){ref-type="fig"} B). This pattern in the localization of Doa4-GFP was identical to the localization of Bro1 that we had previously observed in these same mutant strains ([@bib27]). The inability of Doa4-GFP to localize to endosomal compartments in the absence of Snf7 may, therefore, be due to the requirement for Snf7 in the endosomal localization of Bro1 ([@bib27]). Indeed, as shown in [Fig. 9](#fig9){ref-type="fig"} C, neither Vps24 nor Snf7 coimmunoprecipitated with Doa4 from *VPS4* ^+^ or *vps4*Δ cell extracts. Thus, the ESCRT-III complex does not appear to have a direct role in the recruitment of Doa4 to endosomes.

![**Localization of Doa4-GFP in ESCRT-III mutants.** (A and B) Fluorescence and DIC microscopy of GOY113 (A) and GOY114 (B) cells stained with FM 4-64. Closed arrowheads indicate colocalization of Doa4-GFP and FM 4-64 at class E compartments. Open arrowheads indicate class E compartments at which Doa4-GFP is not localized. Bars, 2.5 μm. (C) Native immunoprecipitations from detergent extracts of total lysates of GOY115 and GOY116 cells.](200403139f9){#fig9}

Discussion
==========

Protein sorting in the MVB pathway requires Bro1, a cytoplasmic protein that associates with endosomal compartments ([@bib27]). Here, we show that *DOA4* overexpression suppresses the defects in MVB transport and restores the multivesicular morphology of endosomes in *bro1* mutant cells. These observations can be explained by our finding that Bro1 associates with Doa4 on endosomal membranes and that the recruitment of Doa4 to endosomes requires Bro1. Thus, our results indicate a key role for Bro1 in regulating the timing and location of Doa4 activity in the MVB pathway.

Recruitment of Doa4 by Bro1
---------------------------

Both Doa4-GFP and Bro1-GFP were associated with endosomal compartments, but upon deletion of the *BRO1* gene, the localization of Doa4-GFP was shifted to the cytoplasm. In contrast, Bro1-GFP remained associated with endosomes regardless of whether the *DOA4* gene had been deleted. Native immunoprecipitation experiments revealed a physical interaction between Doa4 and Bro1, which could reflect direct binding of Doa4 by Bro1 or, alternatively, could be mediated by another component that binds both proteins. In either case, the association of Doa4 with Bro1 occurred predominantly in subcellular fractions containing late endosomal membranes, which is consistent with the ordered recruitment of Bro1 to endosomes followed by the recruitment of Doa4 ([Fig. 10](#fig10){ref-type="fig"}). Consistent with this model, the association of Doa4-GFP with endosomes required Snf7, a component of the ESCRT-III complex. We recently showed that Snf7 is essential for the endosomal localization of Bro1 ([@bib27]), and in mammalian cells, the orthologue of Bro1, Alix/Aip1, binds Chmp4b, which is an orthologue of Snf7 ([@bib19]; [@bib23]; [@bib34]; [@bib38]; [@bib29]). Thus, it is likely that Snf7 has an indirect role in the endosomal localization of Doa4 by functioning to recruit Bro1 to endosomes or to stabilize the association of Bro1 with endosomal membranes. Indeed, we were unable to detect a physical interaction between Doa4 and either Snf7 or Vps24, another component of the ESCRT-III complex. Furthermore, high-copy *DOA4* could not suppress the defects in either CPY or CPS sorting caused by the loss of any ESCRT-III component.

![**Model for the recruitment of Doa4 to endosomes by Bro1.** Bro1 is required for the association of Doa4 with endosomes, where Doa4 catalyzes deubiquitination of MVB cargo proteins. The endosomal recruitment of Bro1, and consequently the recruitment of Doa4, is dependent on Snf7, which oligomerizes on endosomal membranes with the other ESCRT-III components (Vps2, Vps24, and Vps20). After their deubiquitination, MVB cargoes are sorted into lumenal vesicles. Not depicted is the dissociation of Bro1, Doa4, and ESCRT-III proteins from endosomes, which is catalyzed by the Vps4 ATPase.](200403139f10){#fig10}

It is unlikely that Snf7 recruits Bro1 to endosomes by interacting with the Bro1 coiled-coil domain, as this region of Bro1 was not required for its association with endosomal membranes. Furthermore, despite the fact that we identified *DOA4* in a screen for high-copy suppressors of the *bro1* ^Δ^ *^CC^* mutant phenotype, the Bro1 coiled-coil domain is not necessary for Bro1 to interact with Doa4. Nevertheless, the coiled-coil domain is important for Bro1 function, as the transport of GFP-CPS was blocked in *bro1* ^Δ^ *^CC^* mutant cells as effectively as it was in *bro1*Δ cells. Therefore, the recruitment of Doa4 to endosomes is only one aspect of the function of Bro1 in the MVB pathway. The role of the Bro1 coiled-coil domain is not yet clear. Thus far, we have been unable to identify another protein that interacts with this region of Bro1, and we have been unable to detect homo-oligomerization of Bro1 that could be mediated by the coiled-coil domain (unpublished data).

Suppression by high-copy *DOA4*
-------------------------------

The restoration of multivesicular structures upon the overexpression of *DOA4* coincided with the disappearance of class E compartments, which presumably enables the CPY receptor, Vps10, to recycle to the Golgi where it binds newly synthesized CPY-Inv in order to transport this soluble cargo protein to the endosome ([@bib8]; [@bib10]). Accordingly, we have observed that a Vps10-GFP fusion protein was not concentrated at class E compartments in *bro1* mutant cells overexpressing *DOA4* but was, instead, localized to multiple punctate structures (unpublished data), which is similar to its localization in wild-type cells ([@bib7]; [@bib27]).

Interestingly, although high-copy *DOA4* restored the multivesicular morphology of late endosomes and suppressed CPY-Inv secretion by both *bro1* ^Δ^ *^CC^* and *bro1*Δ cells, the transport of GFP-CPS via the MVB pathway was efficiently restored by *DOA4* overexpression only in *bro1* ^Δ^ *^CC^* and not *bro1*Δ cells. Furthermore, the overexpression of *DOA4* in *bro1*Δ cells did not significantly enhance the deubiquitination of CPS, whereas the minor amount of Ub-CPS seen in the *bro1* ^Δ^ *^CC^* strain was completely eliminated by *DOA4* overexpression. These observations are consistent with the ability of Doa4 to be recruited to endosomes in cells expressing the mutant bro1^ΔCC^ protein but not in cells in which Bro1 is completely absent. Moreover, these findings suggest that restoring MVB morphology alone by *DOA4* overexpression is not sufficient for a complete restoration of the MVB pathway. The overexpression of *DOA4* in *bro1*Δ cells may result in excess amounts of Doa4 that could deubiquitinate proteins which regulate the formation of MVB vesicles, but the sorting of cargoes into MVB vesicles per se may be critically dependent on the coordination of Doa4 on endosomal membranes by Bro1 as well as other aspects of Bro1 function in the MVB pathway.

Deubiquitination in the MVB pathway
-----------------------------------

Ubiquitination is tightly controlled by Ub-conjugation enzymes and is counterbalanced by deubiquitination. Both poly- and monoubiquitinated proteins undergo deubiquitination, but few Ub thiolesterases have been assigned to specific substrates ([@bib40]). There are 16 UBPs in *S. cerevisiae*, suggesting that many of these enzymes have highly specific and regulated functions. However, Doa4 probably has a wide variety of substrates. In addition to its role in the removal of monoubiquitin from MVB cargo proteins, Doa4 is likely to function in the removal of polyubiquitin from proteasomal substrates, as Doa4 copurifies with proteasomes that have been isolated from yeast cell extracts ([@bib28]).

Consistent with a role for Bro1 in coordinating Doa4 function are the previous observations that Bro1 is required for the deubiquitination of CPS ([@bib27]) as well as Gap1, an amino acid permease at the plasma membrane that is down-regulated by endocytosis and sorted via the MVB pathway ([@bib25]). Interestingly, in *bro1* mutant cells, Gap1 is recycled to the plasma membrane but, unlike CPS, does not accumulate in its ubiquitinated form. However, ubiquitinated Gap1 is readily detected in *bro1* mutant cells if recycling is blocked, suggesting that in the absence of Bro1, the deubiquitination of Gap1 (and possibly other endocytic cargoes) occurs elsewhere within the cell and may be catalyzed by one of the 15 other UBPs in yeast ([@bib25]).

The suppressor activity of high-copy *DOA4* was abolished if the putative active-site cysteine residue was altered to serine, indicating that suppression most likely occurred through substrate deubiquitination. However, the deubiquitination of cargoes is not essential for MVB sorting because chimeric cargo proteins that are expressed as translational fusions to Ub cannot be deubiquitinated yet are transported efficiently via the MVB pathway ([@bib32]; [@bib35]; [@bib6]). Nevertheless, Doa4 is required for the MVB pathway, as the sorting of MVB cargo proteins is blocked in *doa4* mutant cells ([@bib22]; [@bib32]). In addition to MVB cargoes, Doa4 could deubiquitinate a component of the MVB sorting machinery in order to regulate its activity. It is not known whether class E Vps proteins in yeast are regulated by ubiquitination. In mammalian cells, however, several cytoplasmic proteins that control receptor down-regulation are monoubiquitinated, including Hrs, which is the orthologue of the yeast class E Vps protein, Vps27 ([@bib30]). CIN85 and endophilin are also monoubiquitinated cytoplasmic components in mammalian cells that associate with endosomes ([@bib15]; [@bib2]), and both proteins interact with Alix/Aip1 ([@bib37]; [@bib9]). Like Bro1 in yeast, Alix/Aip1 could recruit a UBP that deubiquitinates CIN85 and endophilin in order to regulate their function and/or localization.

Our results suggest a model in which Bro1 recruits Doa4 to endosomal membranes, thereby controlling the timing and location of Doa4 activity in the MVB pathway ([Fig. 10](#fig10){ref-type="fig"}). The association of Bro1 itself with endosomes occurs after the assembly of the ESCRT-III complex on endosomes ([@bib27]). Similarly, the deubiquitination of MVB cargo proteins occurs downstream of the functions of the ESCRT-I, -II, and -III complexes ([@bib25]) but before enclosure of cargoes within MVB vesicles ([@bib16]). Thus, the Bro1-dependent coordination of Doa4 on endosomal membranes and the subsequent deubiquitination of cargo proteins (and possibly MVB sorting components) is likely to be one of the last steps in the MVB pathway, ensuring that cargo proteins are concentrated at regions of the endosomal membrane where invagination occurs. In mammalian cells, the assembly/budding of HIV-1 depends on ubiquitination of the viral Gag protein (for review see [@bib31]), but a role for deubiquitination in this process has not been described. However, recent studies indicate that Alix/Aip1 interacts with both the ESCRT-I and -III complexes and is involved in viral escape from host cells ([@bib34]; [@bib38]). Future studies may determine whether Alix/Aip1 has a role analogous to Bro1 and functions in the recruitment of a specific UBP to the site of viral budding.

Materials and methods
=====================

Yeast strains and plasmid constructions
---------------------------------------

Standard protocols were used for culturing *S. cerevisiae*, cellular transformations, and spheroplast preparations ([@bib14]). See [Table II](#tbl2){ref-type="table"} for the genotypes of yeast strains used in this work. Gene deletions were constructed by homologous recombination using site-specific deletion cassettes ([@bib14]).

###### Yeast strains used in this work

  Strain    Genotype                                                           Reference
  --------- ------------------------------------------------------------------ -----------
  SEY6210   *MAT*α *leu2-3,112 ura3-52 his3Δ200 trp1-Δ901 lys2-Δ801 suc2-Δ9*   [@bib33]
  BHY10     SEY6210; *leu2-3,112*::pBHY11                                      [@bib17]
  GOY57     BHY10; *bro1* ^ΔCC^                                                This work
  KGY1      BHY10; *bro1Δ::HIS3*                                               This work
  DMY1      SEY6210; *BRO1-GFP::HIS3*                                          This work
  DMY2      SEY6210; *BRO1-GFP::HIS3 vps4Δ::TRP1*                              This work
  DBY15     BHY10; *bro1* ^ΔCC^ *-GFP::HIS3*                                   This work
  DBY18     BHY10; *bro1* ^ΔCC^ *-GFP::HIS3 vps4Δ::TRP1*                       This work
  GOY23     SEY6210; *pep4Δ::LEU2 prb1Δ::LEU2*                                 This work
  GOY71     GOY23; *bro1* ^ΔCC^                                                This work
  DBY43     GOY23; *bro1Δ::HIS3*                                               This work
  GOY74     SEY6210; *DOA4-GFP::HIS3*                                          This work
  GOY75     SEY6210; *DOA4-GFP::HIS3 vps4Δ::TRP1*                              This work
  GOY88     SEY6210; *DOA4-GFP::HIS3 bro1* ^ΔCC^                               This work
  GOY93     SEY6210; *DOA4-GFP::HIS3 bro1* ^ΔCC^ *vps4Δ::TRP1*                 This work
  GOY82     SEY6210; *DOA4-GFP::HIS3 bro1Δ::KAN*                               This work
  GOY83     SEY6210; *DOA4-GFP::HIS3 bro1Δ::KAN vps4Δ::TRP1*                   This work
  GOY69     SEY6210; *BRO1-GFP::HIS3 doa4Δ::KAN*                               This work
  GOY70     SEY6210; *BRO1-GFP::HIS3 doa4Δ::KAN vps4Δ::TRP1*                   This work
  GOY113    SEY6210; *DOA4-GFP::KAN vps4Δ::TRP1 vps24Δ::HIS3*                  This work
  GOY114    SEY6210; *DOA4-GFP::KAN vps4Δ::TRP1 snf7Δ::HIS3*                   This work
  GOY107    GOY23; *DOA4-GFP::KAN BRO1-HA::HIS3*                               This work
  GOY108    GOY23; *DOA4-GFP::KAN BRO1-HA::HIS3 vps4Δ::TRP1*                   This work
  GOY106    GOY23; *DOA4-GFP::KAN bro1* ^ΔCC^ *-HA::HIS3*                      This work
  GOY105    GOY23; *DOA4-GFP::KAN bro1* ^ΔCC^ *-HA::HIS3 vps4Δ::TRP1*          This work
  DBY42     BHY10; *vps4Δ::TRP1*                                               This work
  NLY25     BHY10; *bro1Δ::HIS3 vps4Δ::TRP1*                                   This work
  DBY24     BHY10; *bro1* ^ΔCC^ *vps4Δ::TRP1*                                  This work
  GOY86     BHY10; *vps23Δ::HIS3*                                              This work
  NLY10     BHY10; *vps28Δ::HIS3*                                              This work
  NLY8      BHY10; *vps37Δ::HIS3*                                              This work
  GOY85     BHY10; *vps22Δ::HIS3*                                              This work
  GOY78     BHY10; *vps25Δ::HIS3*                                              This work
  CRY2      BHY10; *vps36Δ::HIS3*                                              This work
  GOY79     BHY10; *vps2Δ::HIS3*                                               This work
  CRY1      BHY10; *vps24Δ::HIS3*                                              This work
  GOY80     BHY10; *vps20Δ::HIS3*                                              This work
  GOY81     BHY10; *snf7Δ::HIS3*                                               This work
  GOY87     BHY10; *vps27Δ::HIS3*                                              This work
  GOY91     BHY10; *nhx1Δ::HIS3*                                               This work
  GOY90     BHY10; *vps60Δ::HIS3*                                              This work

To construct the *bro1* ^Δ^ *^CC^* allele, the SpeI--SalI fragment containing the *BRO1* gene in plasmid pGO187 ([@bib27]) was subcloned into SpeI--SalI-digested pRS413, resulting in plasmid pGO263, which was digested with EcoRV and recircularized using T4 DNA ligase. The resulting plasmid (pGO265) contained the mutant *bro1* ^Δ^ *^CC^* allele consisting of codon 540 adjoined to codon 586. The SpeI--SalI fragment in pGO265 was subcloned into SpeI--SalI-digested pRS416, pRS426, and pRS306, resulting in pGO273, pGO272, and pGO287, respectively. The *bro1* ^Δ^ *^CC^* allele was integrated into the genome in place of the wild-type *BRO1* gene using pGO287 by homologous recombination ([@bib14]). The *doa4* ^C/S^ allele was constructed by PCR and subcloned into pRS202, resulting in pGO309.

Microscopy
----------

GFP and FM 4-64 fluorescence and differential interference contrast (DIC) microscopy was performed using a DMRXA microscope (Leica) equipped with a Cooke Sensicam digital camera (Applied Scientific Instruments). Images were deconvolved using Slidebook^®^ software (Intelligent Imaging Innovations) and processed using Adobe Photoshop 7.0^®^ software (Adobe Systems Inc.). Cells were stained with FM 4-64 using a pulse-chase procedure at 30°C as described previously ([@bib27]). To observe the localization of GFP-CPS, cells were transformed with pGO47, which contains the *GFP-CPS* fusion ([@bib26]). For EM, cells growing logarithmically at 30°C were high pressure frozen, freeze substituted, sectioned, and stained as described in [@bib13]. Thin sections were viewed with a CM10 electron microscope (Philips) and images were captured on film. For quantitation, the number of multivesicular structures and class E compartments were counted in ∼200 randomly chosen cells measuring at least 2.5 μm in diameter.

Genetic screen for high-copy suppressors of *bro1* ^Δ^ *^CC^*
-------------------------------------------------------------

GOY57 cells were transformed with a high-copy library of yeast genomic DNA in plasmid pRS202 (*2* μ *URA3*). Transformants were screened for secreted invertase activity using the agar overlay assay described in [@bib11]. Library plasmids that reliably displayed suppression were recovered and transformed into naïve GOY57 cells to confirm that the suppression was plasmid linked. One plasmid (designated pGO289) identified as a suppressor of the *bro1* ^Δ^ *^CC^* phenotype contained a fragment of chromosome IV. To confirm that the *DOA4* gene in this region of the chromosome was responsible for suppression, the *DOA4* coding sequence was deleted from pGO289 (resulting in pGO302), and the *DOA4* gene alone was subcloned into pRS202 (resulting in pMD10). pMD10 was found to suppress CPY-Inv as effectively as pGO289, whereas pGO302 was incapable of suppression. Quantitative measurements of the amount of secreted invertase activity were performed in triplicate in at least three independent experiments using the liquid assay described in [@bib11].

Immunoprecipitations and Western blotting
-----------------------------------------

Detection of Ub-CPS was performed as described in [@bib20]. In the strains that were examined, the *PEP4* and *PRB1* genes, which encode vacuolar proteases, had been deleted in order to reduce the nonspecific cleavage of Ub from CPS after cell lysis. The amount of Ub-CPS versus CPS in each lane was quantitated using Adobe Photoshop 7.0^®^. For native immunoprecipitations, 20 A~600~ equivalents of yeast cells were converted to spheroplasts, osmotically lysed in 2-ml ice-cold lysis buffer (200 mM sorbitol, 50 mM potassium acetate, 20 mM Hepes, pH 7.2, 2 mM EDTA, supplemented with a protease inhibitor cocktail; Roche), and homogenized on ice. Triton X-100 was added to a final concentration of 0.5%, the lysates were rotated at 4°C for 10 min, and then centrifuged at 16,000 *g* in order to pellet the detergent-insoluble material. Five A~600~ equivalents of the detergent-soluble extract were precipitated by the addition of 10% (vol/vol) TCA, resulting in a sample representing the total lysate. Rabbit anti-GFP polyclonal antiserum (provided by C. Zuker, University of California, San Diego, La Jolla, CA) plus protein A-Sepharose beads or mouse anti-HA mAbs plus γ-bind Sepharose beads (Amersham Biosciences) were added to 10 A~600~ equivalents of the remaining detergent-soluble extract, which was rotated at 4°C for 2 h. Immune complexes were recovered by centrifugation at 4°C, washed twice with ice-cold lysis buffer plus 0.5% Triton X-100, and twice with ice-cold lysis buffer. Bound antigen was eluted by boiling the beads in SDS-PAGE sample buffer. Four A~600~ equivalents of immunoprecipitates and 0.5 A~600~ equivalents of total lysate were resolved by SDS-PAGE, transferred to nitrocellulose, and examined by Western blotting using anti-GFP mAbs (Zymed Laboratories), anti-HA mAbs (Roche), or polyclonal antisera against Snf7 and Vps24 ([@bib3]).

Online supplemental material
----------------------------

Fig. S1 shows that there is not a significant difference in the expression levels of full-length Doa4-GFP in the strains shown in [Fig. 6](#fig6){ref-type="fig"}. Fig. S2 shows the results from a negative control for [Fig. 8](#fig8){ref-type="fig"} in which Bro1-HA is not immunoprecipitated under native conditions by anti-GFP antiserum in the absence of Doa4-GFP expression. Online supplemental material is available at <http://www.jcb.org/cgi/content/full/jcb.200403139/DC1>.
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